CMPX Compass Therapeutics, Inc.
Healthcare · Market cap: $139.4M
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $0 | $0 |
| 2022-Q2 | $1.8M | $0 |
| 2022-Q3 | $269.2K | $0 |
| 2022-Q4 | $2.6M | $200.7K |
| 2023-Q1 | $355.3K | $0 |
| 2023-Q2 | $0 | $0 |
| 2023-Q3 | $0 | $0 |
| 2023-Q4 | $0 | $0 |
| 2024-Q1 | $0 | $0 |
| 2024-Q2 | $0 | $0 |
| 2024-Q3 | $0 | $0 |
| 2024-Q4 | $0 | $0 |
| 2025-Q1 | $0 | $0 |
| 2025-Q2 | $80.3K | $11.4M |
| 2025-Q3 | $0 | $0 |
| 2025-Q4 | $0 | $0 |
| 2026-Q1 | $0 | $0 |
| 2026-Q2 | $75.6K | $0 |
| 2026-Q3 | $2.8K | $0 |
| 2026-Q4 | $18.4K | $0 |
Bought$5.1M42 buy days
Sold$11.6M7 sell days
Net insider flow-$6.4Mnet selling · 5 years
Latest trade2026-10-01Lerner Neil
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2026-10-01 | Buy | Lerner Neil | Other C-suite | 20,000 | $0.92 | $18.4K | 1 |
| 2026-09-24 | Buy | Lerner Neil | Other C-suite | 2,500 | $1.14 | $2.8K | 1 |
| 2026-04-29 | Buy | Anderman Jonathan | General counsel | 25,000 | $1.89 | $47.2K | 1 |
| 2026-04-29 | Buy | Lerner Neil | Other C-suite | 15,000 | $1.89 | $28.4K | 1 |
| 2025-05-27 | Buy | Schuetz Thomas J. | CEO | 10,000 | $2.11 | $21.1K | 1 |
| 2025-04-09 | Sell | GORDON CARL L | Director | 3,571,428 | $1.59 | $5.7M | 1 |
| 2025-04-09 | Sell | ORBIMED ADVISORS LLC | Director | 3,571,428 | $1.59 | $5.7M | 1 |
| 2025-04-07 | Buy | Anderman Jonathan | Other officer | 20,000 | $1.54 | $30.8K | 1 |
| 2025-04-07 | Buy | Lerner Neil | Other C-suite | 20,000 | $1.42 | $28.4K | 1 |
| 2023-03-10 | Buy | Schuetz Thomas J. | CEO | 10,000 | $3.37 | $33.7K | 1 |
| 2023-02-27 | Buy | Schuetz Thomas J. | CEO | 20,000 | $3.98 | $79.6K | 1 |
| 2023-02-15 | Buy | Schuetz Thomas J. | CEO | 20,000 | $3.86 | $77.2K | 1 |
| 2023-01-31 | Buy | Schuetz Thomas J. | CEO | 20,000 | $4.05 | $81.0K | 1 |
| 2023-01-24 | Buy | Schuetz Thomas J. | CEO | 20,000 | $4.19 | $83.8K | 1 |
| 2022-11-25 | Sell | Bisker-Leib Vered | COO | 2 | $4.36 | $9 | 1 |
| 2022-11-23 | Sell | Bisker-Leib Vered | COO | 9,569 | $4.30 | $41.1K | 1 |
| 2022-11-22 | Sell | Bisker-Leib Vered | COO | 14,929 | $4.19 | $62.6K | 1 |
| 2022-11-21 | Sell | Bisker-Leib Vered | COO | 16,035 | $4.34 | $69.6K | 1 |
| 2022-11-18 | Sell | Bisker-Leib Vered | COO | 6,226 | $4.40 | $27.4K | 1 |
| 2022-11-08 | Buy | ORBIMED ADVISORS LLC | Director | 402,000 | $3.21 | $1.3M | 1 |
| 2022-11-08 | Buy | GORDON CARL L | Director | 402,000 | $3.21 | $1.3M | 1 |
| 2022-09-28 | Buy | Schuetz Thomas J. | CEO | 10,000 | $2.32 | $23.2K | 1 |
| 2022-09-26 | Buy | Schuetz Thomas J. | CEO | 15,000 | $2.27 | $34.0K | 1 |
| 2022-09-07 | Buy | Schuetz Thomas J. | CEO | 15,000 | $3.03 | $45.4K | 1 |
| 2022-09-01 | Buy | Schuetz Thomas J. | CEO | 15,000 | $2.83 | $42.4K | 1 |
| 2022-08-17 | Buy | Schuetz Thomas J. | CEO | 15,000 | $3.05 | $45.8K | 1 |
| 2022-08-10 | Buy | Schuetz Thomas J. | CEO | 15,000 | $2.64 | $39.6K | 1 |
| 2022-08-01 | Buy | Schuetz Thomas J. | CEO | 15,000 | $2.58 | $38.7K | 1 |
| 2022-06-21 | Buy | Schuetz Thomas J. | CEO | 20,000 | $2.80 | $56.0K | 1 |
| 2022-06-16 | Buy | Schuetz Thomas J. | CEO | 20,000 | $2.34 | $46.8K | 1 |
| 2022-06-13 | Buy | Schuetz Thomas J. | CEO | 30,000 | $2.29 | $68.7K | 1 |
| 2022-06-06 | Buy | Schuetz Thomas J. | CEO | 30,000 | $2.83 | $84.9K | 1 |
| 2022-06-01 | Buy | Schuetz Thomas J. | CEO | 20,000 | $3.03 | $60.6K | 1 |
| 2022-05-26 | Buy | Schuetz Thomas J. | CEO | 20,000 | $3.04 | $60.8K | 1 |
| 2022-05-23 | Buy | Schuetz Thomas J. | CEO | 18,355 | $2.72 | $49.9K | 1 |
| 2022-05-17 | Buy | Schuetz Thomas J. | CEO | 20,215 | $2.47 | $49.9K | 1 |
| 2022-05-13 | Buy | ORBIMED ADVISORS LLC | Director | 30,722 | $2.49 | $76.5K | 1 |
| 2022-05-13 | Buy | GORDON CARL L | Director | 30,722 | $2.49 | $76.5K | 1 |
| 2022-05-12 | Buy | ORBIMED ADVISORS LLC | Director | 97,094 | $2.35 | $228.2K | 1 |
| 2022-05-12 | Buy | GORDON CARL L | Director | 97,094 | $2.35 | $228.2K | 1 |
| 2022-05-11 | Buy | ORBIMED ADVISORS LLC | Director | 64,700 | $1.79 | $115.8K | 1 |
| 2022-05-11 | Buy | GORDON CARL L | Director | 64,700 | $1.79 | $115.8K | 1 |
| 2022-05-10 | Buy | Schuetz Thomas J. | CEO | 27,836 | $1.80 | $50.1K | 1 |
| 2022-05-10 | Buy | GORDON CARL L | Director | 24,447 | $1.60 | $39.1K | 1 |
| 2022-05-10 | Buy | ORBIMED ADVISORS LLC | Director | 24,447 | $1.60 | $39.1K | 1 |
| 2022-05-09 | Buy | ORBIMED ADVISORS LLC | Director | 90,712 | $1.56 | $141.5K | 1 |
| 2022-05-09 | Buy | GORDON CARL L | Director | 90,712 | $1.56 | $141.5K | 1 |
| 2022-05-06 | Buy | GORDON CARL L | Director | 10,200 | $1.63 | $16.6K | 1 |
| 2022-05-06 | Buy | ORBIMED ADVISORS LLC | Director | 10,200 | $1.63 | $16.6K | 1 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| GORDON CARL L | Director | $1.9M | $5.7M | 2025-04-09 |
| ORBIMED ADVISORS LLC | Director | $1.9M | $5.7M | 2025-04-09 |
| Schuetz Thomas J. | CEO | $1.2M | $0 | 2025-05-27 |
| Bisker-Leib Vered | COO | $0 | $200.7K | 2022-11-25 |
| Anderman Jonathan | General counsel | $78.0K | $0 | 2026-04-29 |
| Lerner Neil | Other C-suite | $78.0K | $0 | 2026-10-01 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
| Window | Insiders | Total | Score | 21 days vs benchmark | 63 days vs benchmark | 126 days vs benchmark | Status |
|---|---|---|---|---|---|---|---|
| 2022-05-06 → 2022-06-21 | 3 | $1.8M | 61 | +36.6% (+38.9% raw) | +44.7% (+57.1% raw) | +138.9% (+139.4% raw) | closed |
| 2020-06-19 | 5 | $18.1M | 58 | – | – | – | closed |
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.